Spinal cord stimulation
Clinical evidence
We are committed to advancing SCS through high-quality robust clinical research on SCS indications using multiple stimulation waveforms, including low-dose, high-dose, tonic, and Differential Target Multiplexed™ spinal cord stimulation (DTM™ SCS).
Lower Limb
86%
of patients with diabetic peripheral neuropathy pain in the lower limbs reported treatment success after receiving SCS therapy for one year.†,1
Upper limb pain
100%
of subjects with upper-limb were satisfied or very satisfied with DTM™ SCS at 12 months.2
Back pain
2 RCTs
Medtronic conducted 2 randomized control trials (RCTs) that evaluated DTM™ SCS versus conventional stimulation.3,4
† Success rates in a population of patients treated with SCS in two studies and followed for five years.